TTR and heart failure: Observations in the UK Biobank showed that carriers of the TTR pathogenic variant p.V142I have reduced TTR levels compared with noncarriers, with low TTR levels associated with increased risks of heart failure, cardiovascular disease, atherosclerotic cardiovascular disease, all-cause mortality, and cardiovascular mortality [9].